Cytotoxic CD4+CD28null T lymphocytes, systemic inflammation and atherosclerotic risk in patients with chronic kidney disease

Nephron - Clinical Practice

Volumn 120, Issue 4, 2012, Pages

  Yadav, Ashok Kumar ^a   Lal, Anupam ^a   Jha, Vivekanand ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Atherosclerosis; CD4 +CD28null cells; Chronic kidney disease; Intima media thickness

Indexed keywords

C REACTIVE PROTEIN; CD28 ANTIGEN; GRANZYME B; INTERLEUKIN 6; PERFORIN; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; GRANZYME;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL SURFACE; CHRONIC KIDNEY DISEASE; COMMON CAROTID ARTERY; CONTROLLED STUDY; DOWN REGULATION; ECHOGRAPHY; FEMALE; FLOW CYTOMETRY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; AGED; BLOOD; CAROTID ARTERY DISEASES; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; COMPLICATION; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULUS FILTRATION RATE; IMMUNOLOGY; MIDDLE AGED;

AGED; ANTIGENS, CD28; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GLOMERULAR FILTRATION RATE; GRANZYMES; HUMANS; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERFORIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865052240     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000338352     Document Type: Article

References (35)

1. Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, Klag MJ, Mailloux LU, Manske CL, Meyer KB, Parfrey PS, Pfeffer MA, Wenger NK, Wilson PW, Wright JT Jr: CONTROLLING the epidemic of cardiovascular disease in chronic renal disease: WHAT do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 1998; 32: 853-906. (Pubitemid 28516321)
2. Foley RN, Parfrey PS, Sarnak MJ: EPIDEMIOLOGY of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9:S16-S23.
3. Muntner P, He J, Astor BC, Folsom AR, Coresh J: TRADITIONAL and nontraditional risk factors predict coronary heart disease in chronic kidney disease: Results from the atherosclerosis risk in communities study. J Am Soc Nephrol 2005; 16: 529-538. (Pubitemid 41725151)
4. Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD: MALNUTRITION-Inflammation complex syndrome in dialysis patients: Causes and consequences. Am J Kidney Dis 2003; 42: 864-881. (Pubitemid 37322905)
5. Papagianni A, Kalovoulos M, Kirmizis D, Vainas A, Belechri AM, Alexopoulos E, Memmos D: CAROTID atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients. Nephrol Dial Transplant 2003; 18: 113-119. (Pubitemid 36104486)
6. Yeun JY, Levine RA, Mantadilok V, Kaysen GA: c-Reactive protein predicts all-Cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000; 35: 469-476. (Pubitemid 30124077)
7. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: INFLAMMATION enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648-658. (Pubitemid 29082891)
8. Knight EL, Rimm EB, Pai JK, Rexrode KM, Cannuscio CC, Manson JE, Stampfer MJ, Curhan GC: KIDNEY dysfunction, inflammation, and coronary events: A prospective study. J Am Soc Nephrol 2004; 15: 1897-1903. (Pubitemid 38822070)
9. Haubitz M, Brunkhorst R: c-Reactive protein and chronic chlamydia pneumoniae infection - long-Term predictors for cardiovascular disease and survival in patients on peritoneal dialysis. Nephrol Dial Transplant 2001; 16: 809-815. (Pubitemid 32257981)
10. Libby P: INFLAMMATION in atherosclerosis. Nature 2002; 420: 868-874. (Pubitemid 36019640)
11. Zal B, Kaski JC, Arno G, Akiyu JP, Xu Q, Cole D, Whelan M, Russell N, Madrigal JA, Dodi IA, Baboonian C: HEAT-shock protein 60-Reactive CD4+CD28null T cells in patients with acute coronary syndromes. Circulation 2004; 109: 1230-1235. (Pubitemid 38372781)
12. Liuzzo G, Biasucci LM, Trotta G, Brugaletta S, Pinnelli M, Digianuario G, Rizzello V, Rebuzzi AG, Rumi C, Maseri A, Crea F: UNUSUAL CD4+CD28null T lymphocytes and recurrence of acute coronary events. J Am Coll Cardiol 2007; 50: 1450-1458. (Pubitemid 47494592)
13. Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, Frye RL, Weyand CM: MONOCLONAL T-Cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000; 101: 2883-2888. (Pubitemid 30415876)
14. Nowik M, Nowacki P, Grabarek J, Drechsler H, Bialecka M, Widecka K, Stankiewicz J, Safranow K: CAN we talk about CD4+CD28-lymphocytes as a risk factor for ischemic stroke? Eur Neurol 2007; 58: 26-33. (Pubitemid 47038157)
15. Sato K, Niessner A, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM: TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque. J Exp Med 2006; 203: 239-250. (Pubitemid 43139661)
16. Betjes MG, Huisman M, Weimar W, Litjens NH: EXPANSION of cytolytic CD4+CD28- T cells in end-stage renal disease. Kidney Int 2008; 74: 760-767.
17. Yadav AK, Jha V: CD4+CD28null cells are expanded and exhibit a cytolytic profile in end-stage renal disease patients on peritoneal dialysis. Nephrol Dial Transplant 2011; 26: 1689-1694.
18. Betjes MG, de Wit EE, Weimar W, Litjens NH: CIRCULATING pro-Inflammatory CD4posCD28null T cells are independently associated with cardiovascular disease in ESRD patients. Nephrol Dial Transplant 2010; 25: 3640-3646.
19. Hurst RT, Ng DW, Kendall C, Khandheria B: CLINICAL use of carotid intima-media thickness: Review of the literature. J Am Soc Echocardiogr 2007; 20: 907-914. (Pubitemid 47016908)
20. Nishizawa Y, Shoji T, Maekawa K, Nagasue K, Okuno S, Kim M, Emoto M, Ishimura E, Nakatani T, Miki T, Inaba M: INTIMA-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2003; 41:S76-S79. (Pubitemid 36278351)
21. Gerli R, Schillaci G, Giordano A, Bocci EB, Bistoni O, Vaudo G, Marchesi S, Pirro M, Ragni F, Shoenfeld Y, Mannarino E: CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 2004; 109: 2744-2748. (Pubitemid 38737922)
22. Liuzzo G, Kopecky SL, Frye RL, O'Fallon WM, Maseri A, Goronzy JJ, Weyand CM: PERTURBATION of the T-Cell repertoire in patients with unstable angina. Circulation 1999; 100: 2135-2139.
23. Alber HF, Duftner C, Wanitschek M, Dorler J, Schirmer M, Suessenbacher A, Frick M, Dichtl W, Pachinger O, Weidinger F: NEOPTERIN, CD4+CD28- lymphocytes and the extent and severity of coronary artery disease. Int J Cardiol 2009; 135: 27-35.
24. Fasth AE, Snir O, Johansson AA, Nordmark B, Rahbar A, Af Klint E, Bjorkstrom NK, Ulfgren AK, van Vollenhoven RF, Malmstrom V, Trollmo C: SKEWED distribution of proinflammatory CD4+CD28null T cells in rheumatoid arthritis. Arthritis Res Ther 2007; 9:R87.
25. Gilani SR, Vuga LJ, Lindell KO, Gibson KF, Xue J, Kaminski N, Valentine VG, Lindsay EK, George MP, Steele C, Duncan SR: cd28 down-Regulation on circulating CD4 T-Cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis. Plos One 2010; 5:e8959.
26. Lamprecht P, Moosig F, Csernok E, Seitzer U, Schnabel A, Mueller A, Gross WL: cd28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener's granulomatosis. Thorax 2001; 56: 751-757. (Pubitemid 32917543)
27. Wang Y, Bai J, Li F, Wang H, Fu X, Zhao T, Xu W, Zhang J, Ni B, Wu Y: CHARACTERISTICS of expanded CD4+CD28null T cells in patients with chronic hepatitis B. Immunol Invest 2009; 38: 434-446.
28. Pingiotti E, Cipriani P, Marrelli A, Liakouli V, Fratini S, Penco M, Giacomelli R: SURFACE expression of fractalkine receptor (CX3CR1) on CD4+/CD28 T cells in RA patients and correlation with atherosclerotic damage. Ann NY Acad Sci 2007; 1107: 32-41. (Pubitemid 47528779)
29. Bryl E, Vallejo AN, Weyand CM, Goronzy JJ: DOWN-Regulation of CD28 expression by TNF-Alpha. J Immunol 2001; 167: 3231-3238.
30. Jairam A, Das R, Aggarwal PK, Kohli HS, Gupta KL, Sakhuja V, Jha V: IRON status, inflammation and hepcidin in ESRD patients: The confounding role of intravenous iron therapy. Indian J Nephrol 2010; 20: 125-131.
31. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furberg CD, Psaty BM: ELEVATIONS of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003; 107: 87-92. (Pubitemid 36070938)
32. Weyand CM, Brandes JC, Schmidt D, Fulbright JW, Goronzy JJ: FUNCTIONAL properties of CD4+ CD28- T cells in the aging immune system. Mech Ageing Dev 1998; 102: 131-147. (Pubitemid 28353534)
33. Link A, Selejan S, Hewera L, Walter F, Nickenig G, Bohm M: ROSUVASTATIN induces apoptosis in CD4(+)CD28 (null) T cells in patients with acute coronary syndromes. Clin Res Cardiol 2011; 100: 147-158.
34. Brugaletta S, Biasucci LM, Pinnelli M, Biondi-Zoccai G, Di Giannuario G, Trotta G, Liuzzo G, Crea F: NOVEL anti-Inflammatory effect of statins: Reduction of CD4+CD28null T lymphocyte frequency in patients with unstable angina. Heart 2006; 92: 249-250. (Pubitemid 43131971)
35. Tikiz C, Utuk O, Pirildar T, Bayturan O, Bayindir P, Taneli F, Tikiz H, Tuzun C: EFFECTS of angiotensin-Converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritis. J Rheumatol 2005; 32: 2095-2101. (Pubitemid 41587851)